Hematology and Oncology- Physiology Flashcards

1
Q

Hematopoiesis- organs

A

“Young Liver Synthesizes Blood”

Yolk Sac
Liver
Spleen
Bone Marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hemoglobin development

A

“Always Alpha, Gamma Goes, Becomes Beta”

gamma-epsilon (Embryonic- yolk sac)
alpha2-gamma2 (HbF- fetus)
alpha2-beta2 (HbA1- adult)
alpha2-delta2 (HbA2- adult)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Characteristics of HbF

A

Less 2,3- BPG affinity (makes sense because it is shifting the curve left, to increase O2 affinity/ O2 binding- to extract from mom’s HbA1 and HbA2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ABO classification

A

A- Has A surface antigens, make IgM Abs to B
B- Has B surface antigens, makes IgM Abs to A
AB- has both A and B surface antigens; makes no Abs
O- has no surface antigens; makes IgM Abs to both A and B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rh classification

A

Rh+ –> has D surface antigens; does not make antibodies
Rh- –> has no D surface antigens; makes IgG Abs to D

Clinically important when mom is Rh- and kid is Rh+ (mom makes Abs to kids blood, that can potentially kill kid)

Therefore, give mom RhoGam (Anti-D IgG; to clear fetuses RBCs and prevent her from making her own anti-D IgG)

Gets worse during subsequent pregnancies, if not treated during the first one (because pre-formed Anti-D IgG are in mom’s circulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Erythroblastosis fetalis- S&S

A

Hemolytic disease of the newborn

Neonates present with purpura, HSM, anemia, edema, ascites (placenta is pale, thick and enlarged)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ABO hemolytic disease of the newborn

A

Most common

Don’t hear about as often, because antibodies to A or B antigens that are not present on the cell is generally IgM (which does not cross the placenta)

Occasionally (most common in a Type O mom) with a A or B fetus, IgG is produced that then reacts with kids RBCs

This generally does not worsen with subsequent pregnancies, and kid presents with mild jaundice that is corrected with phototherapy/ exchange transfusion when baby is delivered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hemoglobin electrophoresis

A

“A Fat Santa Claus”

Anode (+)

HbA
HbF
HbS (glutamic acid (-) is replaced with valine (neutral))
HbC (glutamic acid (-) is replaced with lysine (+))

Cathode (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Intrinsic pathway

A

12, 11, 9, 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Extrinsic pathway

A

7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Combined pathway

A

10, 5, 2, 1, 13 (stabilizes 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Procoagulation

A

Oxidized Vitamin K (enzyme: epoxide reductase- inhibited by Warfarin) –> Reduced Vitamin K –> activates 2, 7, 9, 10, C, S (via gamma glutamyl transferase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anticoagulation- Protein C

A

Protein C (via thrombin-thrombomodulin complex) –> activated Protein C (via protein S) –> cleaves and inactivates Va and VIIIa

Therefore Protein C plays a role in anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anticoagulation- Plasminogen

A

Plasminogen (via tPA) –> Plasmin –> Fibrinolysis (1. cleaves fibrin mesh, 2. destruction of coagulation factors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anticoagulation- Antithrombin

A

Main targets of antithrombin: thrombin and Xa

Inhibits activated form of factors II, VII, IX, X, XI, XII

Heparin enhances the activity of antithrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factor V Leiden mutation

A

Produces a factor V that is resistant to being inactivated by Protein C –> thereby makes individual in a hypercoagulable state

17
Q

tPA

A

Activates Plasminogen to Plasmin

Used clinically as a thrombolytic

18
Q

Platelet pathway (primary hemostasis)

A

Injury –> Exposure –> Adhesion –> Activation –> Aggregation

19
Q

Injury

A

Endothelial damage

20
Q

Exposure

A

vWF binds to exposed collagen

vWF is in endothelial cells and platelet granules

21
Q

Adhesion

A

Platelets bind vWF via GpIb receptors –> Platelets undergo a conformational change –> Platelets release ADP and Ca2+ –> ADP helps platelet adheres to endothelium

22
Q

Activation

A

ADP binding to receptor induces GpIIb/IIIa expression at platelet surface

23
Q

Aggregation

A

Fibrinogen binds GpIIb/IIIa receptors and links platelets

24
Q

Pro-aggregation factors

A

TXA2 (released by platelets)
Decrease blood flow
Increase platelet aggregation

25
Q

Anti-aggregation factors

A

PGI2 and NO (released by endothelial cells)
Increase blood flow
Decrease platelet aggregation

26
Q

Aspirin

A

Irreversibly inhibits COX (TXA2 synthesis)

27
Q

Clopidogrel

A

Inhibits ADP-induced expression of GpIIb/IIIa

28
Q

Abciximab

A

Inhibit GpIIb/IIIa directly

29
Q

Ristocetin

A

Activates vWF to bind to GpIb

Failure of agglutination indicates von Willibrand disease and Bernard Soulier syndrome (GpIb deficiency)

30
Q

Glanzmann throbastehenia

A

Deficiency of GpIIb/IIIa